Patents by Inventor Stefan Jenewein

Stefan Jenewein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10590404
    Abstract: The present invention pertains to the field of amylases with reduced disposition to form deamidation products, particularly alpha-amylases, and compositions comprising such amylases. Also described are means and methods for producing such amylases, and uses of amylases and amylase-comprising compositions, for example for cleaning starch-containing stains, textile desizing, starch liquefaction and saccharification, baking and brewing. The invention also discloses means for increasing amylase purity during fermentation, formulation and storage of amylase or amylase-containing formulations.
    Type: Grant
    Filed: April 15, 2015
    Date of Patent: March 17, 2020
    Assignee: BASF SE
    Inventors: Stefan Jenewein, Stefan Niedermaier
  • Patent number: 10507340
    Abstract: Provided herein are oral care compositions comprising antifreeze proteins (AFPs) useful in methods of repairing or inhibiting dental erosion, promoting dental remineralization, and/or enhancing the anti-cavity effects of fluoride.
    Type: Grant
    Filed: October 25, 2016
    Date of Patent: December 17, 2019
    Assignee: BASF SE
    Inventors: Nina Schneider, Thomas Subkowski, Stefan Jenewein, Marvin Karos, Claus Bollschweiler, Volker Wendel, Jianhong Qiu, LaTonya Kilpatrick-Liverman, Lynette Zaidel
  • Publication number: 20190292494
    Abstract: A composition comprising component (a) at least one phenyl boronic acid and component (b) pentane-1,2-diol and optionally one or more further diols wherein the composition is liquid at 20° C. and 101.3 kPa. Said composition stabilizes serine protease.
    Type: Application
    Filed: November 21, 2017
    Publication date: September 26, 2019
    Inventors: Stefan Jenewein, Max-Philipp Fischer, Hans Wolfgang Hoeffken, Janosch Harald Achenbach, Oliver Spangenberg, Allan Francis Cunningham, Jesper Nielsen
  • Publication number: 20190201721
    Abstract: Provided herein are oral care compositions comprising HABP, which are useful in methods of repairing or inhibiting dental erosion, promoting dental remineralization, and/or enhancing the anti-cavity effects of fluoride.
    Type: Application
    Filed: October 25, 2016
    Publication date: July 4, 2019
    Inventors: Nina Schneider, Thomas Subkowski, Stefan Jenewein, Marvin Karos, Claus Bollschweiler, Volker Wendel, Thorsten Henkes, Sandra Facey, Bernhard Hauer
  • Publication number: 20190112612
    Abstract: The present invention generally relates to the field of fermentation technology and microorganisms useful for such fermentations. The invention also relates to materials including nucleic acids and proteins useful for altering fermentation characteristics of microorganisms, and to microorganisms comprising such nucleic acids and/or proteins.
    Type: Application
    Filed: December 8, 2016
    Publication date: April 18, 2019
    Inventors: Max Fabian Felle, Stefan Jenewein, Kerstin Hage, Holger Hartmann
  • Publication number: 20190022429
    Abstract: Provided herein are oral care compositions comprising antifreeze proteins (AFPs) useful in methods of repairing or inhibiting dental erosion, promoting dental remineralization, and/or enhancing the anti-cavity effects of fluoride.
    Type: Application
    Filed: October 25, 2016
    Publication date: January 24, 2019
    Inventors: Nina Schneider, Thomas Subkowski, Stefan Jenewein, Marvin Karos, Claus Bollschweiler, Volker Wendel, Jianhong Qiu, LaTonya Kilpatrick-Liverman, Lynette Zaidel
  • Publication number: 20180371444
    Abstract: The present invention generally relates to the field of fermentation technology and microorganisms useful for such fermentations. The invention also relates to materials including nucleic acids and proteins useful for altering fermentation characteristics of microorganisms, and to microorganisms comprising such nucleic acids and/or proteins. In particular, the invention relates to materials for conferring, modifying or reducing microbial stress resistance.
    Type: Application
    Filed: December 8, 2016
    Publication date: December 27, 2018
    Inventors: Max Fabian Felle, Stefan Jenewein, Handtke Stefan, Birgit Voigt, Thomas Schweder, Michael Hecker
  • Publication number: 20180353416
    Abstract: Provided herein are oral care compositions comprising partially hydrolyzed plant protein, which are useful in methods of repairing or inhibiting dental erosion, promoting dental remineralization, and/or enhancing the anti-cavity effects of fluoride.
    Type: Application
    Filed: October 25, 2016
    Publication date: December 13, 2018
    Inventors: LaTonya KILPATRICK-LIVERMAN, Jianhong QIU, Lynette ZAIDEL, Thomas SUBKOWSKI, Stefan JENEWEIN, Marvin KAROS, Claus BOLLSCHWEILER, Volker WENDEL, Nina SCHNEIDER, Ralph Peter SANTARPIA
  • Publication number: 20180318200
    Abstract: Provided herein is a mouthwash comprising partially hydrolyzed plant protein, which is useful, e.g., in methods of repairing or inhibiting dental erosion, promoting dental remineralization, and/or enhancing the anti-cavity effects of fluoride.
    Type: Application
    Filed: October 25, 2016
    Publication date: November 8, 2018
    Inventors: LaTonya KILPATRICK-LIVERMAN, Jianhong QIU, Lynette ZAIDEL, Thomas SUBKOWSKI, Stefan JENEWEIN, Marvin KAROS, Claus BOLLSCHWEILER, Volker WENDEL, Nina SCHNEIDER, Ralph Peter SANTARPIA
  • Publication number: 20180303740
    Abstract: Provided herein are oral care compositions comprising Hydrophobin-like proteins (HLPs), which are useful in methods of repairing or inhibiting dental erosion, promoting dental remineralization, and/or enhancing the anti-cavity effects of fluoride.
    Type: Application
    Filed: October 25, 2016
    Publication date: October 25, 2018
    Inventors: Nina Schneider, Thomas Subkowski, Stefan Jenewein, Marvin Karos, Claus Bollschweiler, Volker Wendel, Jianhong Qiu, LaTonya Kilpatrick-Liverman, Lynette Zaidel, Melanie Melcher, Thorsten Henkes, Sandra Facey, Bernhard Hauer
  • Publication number: 20170137530
    Abstract: The invention relates to engineered polypeptides comprising Fc variants and their uses. More specifically, Fc variants are described exhibiting reduced effector function. These variants cause a benefit for a patient suffering from a disease which could be treated with an antibody for which it is desirable to reduce the effector function elicited by antibodies.
    Type: Application
    Filed: September 7, 2016
    Publication date: May 18, 2017
    Applicant: Roche Glycart AG
    Inventors: Monika BAEHNER, Stefan JENEWEIN, Manfred KUBBIES, Ekkehard MOESSNER, Tilman SCHLOTHAUER
  • Publication number: 20170044509
    Abstract: The present invention pertains to the field of amylases, particularly alpha-amylases, and compositions comprising such amylases. Also described are means and methods for producing such amylases, and uses of amylases and amylase-comprising compositions, for example for cleaning starch-containing stains, textile desizing, starch liquefaction and saccharification, baking and brewing. The invention also discloses means for increasing amylase purity during fermentation, formulation and storage of amylase or amylase-containing formulations.
    Type: Application
    Filed: April 15, 2015
    Publication date: February 16, 2017
    Inventors: Stefan Jenewein, Stefan Niedermaier
  • Publication number: 20170022531
    Abstract: A process for production of a protein of interest in a microbial host organism comprising the steps of: a) constructing a vector comprising a gene for the protein of interest and a functional frr gene and no antibiotic resistance gene, b) transforming a host organism having an inactivated chromosomal frr gene with the vector obtained in a), c) culturing the transformed host organism obtained in b) under conditions allowing the expression of the gene of interest in the host organism and d) isolating the protein of interest.
    Type: Application
    Filed: December 12, 2014
    Publication date: January 26, 2017
    Applicant: BASF SE
    Inventors: Stefan Jenewein, Max Fabian Felle, Jan Reyelt
  • Publication number: 20150239981
    Abstract: The invention relates to engineered polypeptides comprising Fc variants and their uses. More specifically, Fc variants are described exhibiting reduced effector function. These variants cause a benefit for a patient suffering from a disease which could be treated with an antibody for which it is desirable to reduce the effector function elicited by antibodies.
    Type: Application
    Filed: January 22, 2015
    Publication date: August 27, 2015
    Applicant: Roche Glycart AG
    Inventors: Monika BAEHNER, Stefan JENEWEIN, Manfred KUBBIES, Ekkehard MOESSNER, Tilman SCHLOTHAUER
  • Patent number: 8969526
    Abstract: The invention relates to engineered polypeptides comprising Fc variants and their uses. More specifically, Fc variants are described exhibiting reduced effector function. These variants cause a benefit for a patient suffering from a disease which could be treated with an antibody for which it is desirable to reduce the effector function elicited by antibodies.
    Type: Grant
    Filed: March 27, 2012
    Date of Patent: March 3, 2015
    Assignee: Roche Glycart AG
    Inventors: Monika Baehner, Stefan Jenewein, Manfred Kubbies, Ekkehard Moessner, Tilman Schlothauer
  • Patent number: 8883975
    Abstract: The invention provides anti-IL-18R1 antibodies and methods of using the same.
    Type: Grant
    Filed: August 25, 2011
    Date of Patent: November 11, 2014
    Assignee: Hoffmann-La Roche, Inc.
    Inventors: Michael Brandt, Jens Fischer, Stefan Jenewein, Klaus Kaluza, Eileen Samy, Stefan Seeber
  • Publication number: 20130266565
    Abstract: The invention provides a fusion protein comprising an antibody that binds to a human major histocompatibility complex presenting a peptidic fragment of a hepatitis-B-virus protein and an anti-viral cytokine and methods of using the same.
    Type: Application
    Filed: February 4, 2013
    Publication date: October 10, 2013
    Inventors: Stefan Jenewein, Erhard Kopetzki, Stefan Ries, Georg Tiefenthaler
  • Publication number: 20120251531
    Abstract: The invention relates to engineered polypeptides comprising Fc variants and their uses. More specifically, Fc variants are described exhibiting reduced effector function. These variants cause a benefit for a patient suffering from a disease which could be treated with an antibody for which it is desirable to reduce the effector function elicited by antibodies.
    Type: Application
    Filed: March 27, 2012
    Publication date: October 4, 2012
    Inventors: Monika Baehner, Stefan Jenewein, Manfred Kubbies, Ekkehard Moessner, Tilman Schlothauer
  • Publication number: 20120156198
    Abstract: The invention provides anti-IL-18R1 antibodies and methods of using the same.
    Type: Application
    Filed: August 25, 2011
    Publication date: June 21, 2012
    Inventors: Michael Brandt, Jens Fischer, Stefan Jenewein, Klaus Kaluza, Eileen Samy, Stefan Seeber